Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Inhibitory effects of isoflavones on tumor growth and cachexia in newly established cachectic mouse models carrying human stomach cancers.

Yanagihara K, Takigahira M, Mihara K, Kubo T, Morimoto C, Morita Y, Terawaki K, Uezono Y, Seyama T.

Nutr Cancer. 2013;65(4):578-89. doi: 10.1080/01635581.2013.776089.

PMID:
23659450
2.

New cancer cachexia rat model generated by implantation of a peritoneal dissemination-derived human stomach cancer cell line.

Terawaki K, Sawada Y, Kashiwase Y, Hashimoto H, Yoshimura M, Suzuki M, Miyano K, Sudo Y, Shiraishi S, Higami Y, Yanagihara K, Kase Y, Ueta Y, Uezono Y.

Am J Physiol Endocrinol Metab. 2014 Feb 15;306(4):E373-87. doi: 10.1152/ajpendo.00116.2013. Epub 2013 Dec 17.

3.

Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.

Raffoul JJ, Banerjee S, Singh-Gupta V, Knoll ZE, Fite A, Zhang H, Abrams J, Sarkar FH, Hillman GG.

Cancer Res. 2007 Mar 1;67(5):2141-9.

4.

Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis.

Zhou JR, Mukherjee P, Gugger ET, Tanaka T, Blackburn GL, Clinton SK.

Cancer Res. 1998 Nov 15;58(22):5231-8.

5.
6.
7.

Capecitabine improves cancer cachexia and normalizes IL-6 and PTHrP levels in mouse cancer cachexia models.

Fujimoto-Ouchi K, Onuma E, Shirane M, Mori K, Tanaka Y.

Cancer Chemother Pharmacol. 2007 May;59(6):807-15. Epub 2006 Sep 29.

PMID:
17009035
8.

Soy extract inhibits mammary adenocarcinoma growth in a syngeneic mouse model.

Hewitt AL, Singletary KW.

Cancer Lett. 2003 Mar 31;192(2):133-43.

PMID:
12668277
9.

Novel anti-angiogenic effects of formononetin in human colon cancer cells and tumor xenograft.

Auyeung KK, Law PC, Ko JK.

Oncol Rep. 2012 Dec;28(6):2188-94. doi: 10.3892/or.2012.2056. Epub 2012 Sep 26.

PMID:
23023137
10.

Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.

Li X, Wang X, Ye H, Peng A, Chen L.

Cancer Chemother Pharmacol. 2012 Sep;70(3):425-37. doi: 10.1007/s00280-012-1923-x. Epub 2012 Jul 20.

PMID:
22814678
11.

Genistein induces maturation of cultured human breast cancer cells and prevents tumor growth in nude mice.

Constantinou AI, Krygier AE, Mehta RR.

Am J Clin Nutr. 1998 Dec;68(6 Suppl):1426S-1430S.

PMID:
9848511
12.

Soy for breast cancer survivors: a critical review of the literature.

Messina MJ, Loprinzi CL.

J Nutr. 2001 Nov;131(11 Suppl):3095S-108S. Review.

13.

P276-00, a novel cyclin-dependent inhibitor induces G1-G2 arrest, shows antitumor activity on cisplatin-resistant cells and significant in vivo efficacy in tumor models.

Joshi KS, Rathos MJ, Mahajan P, Wagh V, Shenoy S, Bhatia D, Chile S, Sivakumar M, Maier A, Fiebig HH, Sharma S.

Mol Cancer Ther. 2007 Mar;6(3):926-34.

14.
15.

Anticarcinogenic effects of isoflavones may be mediated by genistein in mouse mammary tumor virus-induced breast cancer.

Mizunuma H, Kanazawa K, Ogura S, Otsuka S, Nagai H.

Oncology. 2002;62(1):78-84.

PMID:
11810047
16.

The effect of the phytoestrogens genistein, daidzein, and equol on the growth of tamoxifen-resistant T47D/PKC alpha.

Tonetti DA, Zhang Y, Zhao H, Lim SB, Constantinou AI.

Nutr Cancer. 2007;58(2):222-9.

PMID:
17640169
17.
18.

Effect of FR143430, a novel cytokine suppressive agent, on adenocarcinoma colon26-induced cachexia in mice.

Yamamoto N, Kawamura I, Nishigaki F, Tsujimoto S, Naoe Y, Inami M, Elizabeth L, Manda T, Shimomura K.

Anticancer Res. 1998 Jan-Feb;18(1A):139-44.

PMID:
9568068
19.

Soy-derived isoflavones inhibit the growth of adult T-cell leukemia cells in vitro and in vivo.

Yamasaki M, Fujita S, Ishiyama E, Mukai A, Madhyastha H, Sakakibara Y, Suiko M, Hatakeyama K, Nemoto T, Morishita K, Kataoka H, Tsubouchi H, Nishiyama K.

Cancer Sci. 2007 Nov;98(11):1740-6. Epub 2007 Aug 28.

20.

Membrane fluidity, invasiveness and dynamic phenotype of metastatic prostate cancer cells after treatment with soy isoflavones.

Ajdžanović V, Mojić M, Maksimović-Ivanić D, Bulatović M, Mijatović S, Milošević V, Spasojević I.

J Membr Biol. 2013 Apr;246(4):307-14. doi: 10.1007/s00232-013-9531-1. Epub 2013 Feb 16.

PMID:
23417033

Supplemental Content

Support Center